Showing results (91-100 of 7,984) with videos related to
Sort By:
Pageof 799
Current Medicinal Chemistry|April 12, 2012
Biomarkers determining cardiovascular risk in patients with kidney diseaseG Siasos, D Tousoulis, S Michalea, et al.Current Medicinal Chemistry|April 18, 2012
The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical developmentB-F Ruan, H-L ZhuCurrent Medicinal Chemistry|January 20, 2012
Advances in the research of β-ketoacyl-ACP synthase III (FabH) inhibitorsH-J Zhang, Z-L Li, H-L ZhuCurrent Medicinal Chemistry|January 20, 2012
New developments in the diagnosis and management of resistant hypertensionA Oliveras, A de la SierraCurrent Medicinal Chemistry|January 20, 2012
Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactionsA R Neves, M Lucio, J L C Lima, et al.Current Medicinal Chemistry|January 20, 2012
Nonmuscle myosin heavy chain and histone H3 are intracellular binding partners of lithospermic acid B and mediate its antiproliferative effect on VSMCsY H Cho, E Y Lim, J M Kim, et al.Current Medicinal Chemistry|January 20, 2012
Gemcitabine: a critical nucleoside for cancer therapyD S Gesto, N M F S A Cerqueira, P A Fernandes, et al.Current Medicinal Chemistry|December 17, 2011
Left-right asymmetry in embryonic development and breast cancer: common molecular determinants?J Wilting, M HagedornCurrent Medicinal Chemistry|December 17, 2011
Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's diseaseM Cuadrado-Tejedor, A García-Osta, A Ricobaraza, et al.Current Medicinal Chemistry|December 17, 2011
Rational targeting of peroxisome proliferating activated receptor subtypesD K Nevin, D G Lloyd, D FaynePageof 799